Irina Karavanov

Title: Irina Karavanov: Innovator in Cancer Treatment

Introduction

Irina Karavanov is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. With a total of 3 patents, her work focuses on inhibiting unwanted cell proliferation, particularly in the context of tumors.

Latest Patents

Karavanov's latest patents include groundbreaking methods for treating cancer. One of her notable inventions is a method of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling. This application is directed to compositions and methods for inhibiting angiogenesis and treating or preventing unwanted cell proliferation, including tumors, by inhibiting the hedgehog pathway. Another significant patent involves methods of treating pancreatic or liver cancer using hedgehog antagonists, which also focuses on inhibiting angiogenesis and unwanted cell proliferation.

Career Highlights

Irina Karavanov is currently associated with Curis, Inc., where she continues to advance her research in cancer therapies. Her work has been instrumental in developing new approaches to combat cancer, particularly through the inhibition of the hedgehog signaling pathway.

Collaborations

Throughout her career, Karavanov has collaborated with esteemed colleagues, including Henryk T Dudek and Carmen Pepicelli. These collaborations have further enriched her research and contributed to the development of innovative cancer treatment methods.

Conclusion

Irina Karavanov stands out as a dedicated inventor in the field of cancer treatment, with her innovative patents paving the way for new therapeutic strategies. Her contributions are vital in the ongoing fight against cancer, showcasing the importance of research and innovation in medicine.